Are insiders buying CLOV stock?

Yes — 2 distinct insiders have bought CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Aug 14, 2025.

How much CLOV stock have insiders bought?

Insiders have bought a combined $3.0M of CLOV across 8 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in CLOV?

A cluster buy is two or more distinct CLOVER HEALTH INVESTMENTS, CORP. /DE insiders — officers, directors, or 10% owners — each buying CLOV on the open market within a rolling window. CLOV has 2 detected cluster buys to date.

Where does this CLOV insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

CLOV insider buying

2 cluster buys

CLOVER HEALTH INVESTMENTS, CORP. /DE · Healthcare

When two or more insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE buy CLOV on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in CLOV plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$3.0M

Market cap

$2.7B

Detected clusters

Aug 7 – Aug 13, 2025
Detected Aug 13, 2025
2 insiders
Total bought
$998.4K
Market cap
$2.7B
May 16 – Aug 9, 2024
Detected Aug 9, 2024
2 insiders
Total bought
$2.0M
Market cap
$2.7B

All notable open-market buys in CLOV

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Aug 13, 2025	Loengard Anna Ucluster Director	14,500	$2.59	$37.6K	SEC ↗
Aug 13, 2025	Loengard Anna Ucluster Director	12,000	$2.60	$31.2K	SEC ↗
Aug 7, 2025	Garipalli Vivekcluster Director, 10% Owner	415,000	$2.24	$929.6K	SEC ↗
Aug 9, 2024	Garipalli Vivekcluster Director, 10% Owner	531,700	$1.88	$999.6K	SEC ↗
Jun 17, 2024	Garipalli Vivekcluster Director, 10% Owner	877,567	$1.14	$1.0M	SEC ↗
May 17, 2024	Loengard Anna Ucluster Director	10,000	$0.93	$9.3K	SEC ↗
May 16, 2024	Loengard Anna Ucluster Director	15,600	$0.96	$15.0K	SEC ↗
May 16, 2024	Loengard Anna Ucluster Director	1,485	$0.94	$1.4K	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

CLOV insider buying — FAQ

Are insiders buying CLOV stock?: Yes — 2 distinct insiders have bought CLOV (CLOVER HEALTH INVESTMENTS, CORP. /DE) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Aug 14, 2025.
How much CLOV stock have insiders bought?: Insiders have bought a combined $3.0M of CLOV across 8 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in CLOV?: A cluster buy is two or more distinct CLOVER HEALTH INVESTMENTS, CORP. /DE insiders — officers, directors, or 10% owners — each buying CLOV on the open market within a rolling window. CLOV has 2 detected cluster buys to date.
Where does this CLOV insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in CLOV

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy CLOV within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding CLOV.